A high-pressure ventilator prototype developed by NASA engineers to help coronavirus patients was approved by the Food and Drug Administration on Thursday, according to NASA.
The approval is for use of the ventilator specifically for coronavirus patients under the FDA's ventilator Emergency Use Authorization, established by the agency on March 24."This FDA authorization is a key milestone in a process that exemplifies the best of what government can do in a time of crisis," NASA Administrator Jim Bridenstine said in a statement.
On MAIA, Boland has worked with epidemiologists to determine the data they would need from the mission. You might not be able to go to the moon. But, with this new NASA competition, your idea couldOn VITAL, Boland acted as the operations lead to create a communication pathway between engineers, designers and visualization specialists with doctors, nurses, respiratory therapists and intensivists .
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Could Remdesivir Be the First FDA-Approved Treatment for the Coronavirus?Dr. Fauci and President Trump hope so, based on an NIAID study released Wednesday, though there are reasons to restrain optimism.
続きを読む »
People should not rely on results of antibody tests, former FDA commissioner saysAs coronavirus antibody tests become more available to the general public, Dr. Scott Gottlieb, former commissioner of the Food and Drug Administration, tells TODAY: “I don’t think individuals should rely on the results” because “tests on the market now are very variable in quality.” He warns that the tests have “high false positive results” and could make people think are safe from the virus when they are not.
続きを読む »
Dr. Fauci says remdesivir trial shows drug has promise as FDA plans to announce emergency use'What it has proven is a drug can block this virus,' Fauci said Wednesday while speaking to reporters at the White House.
続きを読む »
US FDA may announce emergency use of Gilead's coronavirus drugExperimental drug has proved effective against the new coronavirus in a major study, shortening the time it takes for patients to recover by four days on average, US government and company officials say.
続きを読む »
U.S. FDA moving with 'lightning speed' on Gilead's COVID-19 drug: BloombergThe U.S. Food and Drug Administration is working at 'lightning speed' to review data on Gilead Sciences Inc's experimental antiviral drug remdesivir in treating COVID-19 disease, the head of the agency told Bloomberg in an interview.
続きを読む »
FDA moving at 'lightning speed' on remdesivir drug as coronavirus treatmentFDA Commissioner Stephen Hahn says the agency is moving at 'lightning speed' on remdesivir but must look at 'the totality of data' before issuing emergency use authorization of the drug.
続きを読む »